After the significant drop in prices at the start of the week, investors dared to return more strongly to the European stock markets on Wednesday. the Dax increased 1.4 percent to 15,423 points. Bargain hunters were quick to come, the stockbrokers explained. Overall, analysts expect strong fluctuations for the Dax in the coming weeks.
The further rise in outlook for the full year at SAP has not convinced investors. Shares of the software company slipped minus 2.5 percent at the end of the Dax. Expectations have only been raised slightly, a stockbroker said. In addition, investors had hoped for more sales in the second quarter. Analyst Konstantin Oldenburger of online broker CMC Markets criticized the fact that growth in promising cloud business lags behind that of rival Oracle. Software AG has also failed to score points with investors with its balance sheet. The share lost 0.4 percent in the M-Dax. Papers from semiconductor maker Infineon, on the other hand, rose 3.3% among Dax favorites after Dutch chip supplier ASML raised its forecast due to strong global demand for semiconductors. ASML shares gained 3.1%.
After the United States, the pharmaceutical company Bayer is also authorized to market its new heart drug Vericiguat in Europe. The European Commission has approved the drug for the EU. Bayer expects record sales of 500 million euros from Vericiguat. Leverkusen group shares climbed 1.7%.
Krones shares rose nearly six percent. In the run-up to the lifting of Covid-19 restrictions, the beverage bottling plant markets have recovered faster than expected, wrote expert Daniel Gleim of analysis firm Stifel. This removes the biggest burden on the stocks. On Wall Street, the Dow Jones closed 0.8% higher. Coca-Cola papers, which sometimes improved by three percent, were in demand. The company has exceeded high expectations with its quarterly results, he said.